IDG-Accel China Growth Fund III L.P.

All filings by IDG-Accel China Growth Fund III L.P. on record concern CASI Pharmaceuticals, Inc. We count 2 filings, every one of them for a trade on 7 March 2013.

Every open-market trade on record is a purchase: 2 purchases, and no sale. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2016 to date brings 2 purchases and no sales.

The latest filing, published on 27 January 2016, reports an open-market purchase in CASI Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.